Avian Influenza: Global Surveillance and Pandemic Preparedness
By Dr. Zubair Khalid, DVM, MS, PhD ·

Key Takeaways
- Highly pathogenic avian influenza (HPAI) viruses, particularly H5N1 clade 2.3.4.4b, are exhibiting unprecedented geographic spread and reassortment with local strains, driven by migratory wild birds. This has led to mass mortality in domestic and wild birds across multiple continents and spillover into numerous mammal species.
- Global surveillance relies on integrated genomic sequencing, epidemiological data, and ecological monitoring coordinated by organizations like WOAH and the CDC, utilizing tools such as real-time RT-PCR and whole genome sequencing for early detection and risk assessment.
- Recent spillover events into dairy cattle in the United States, with documented mammal-to-mammal transmission and high viral loads in milk, highlight the evolving zoonotic potential of HPAI viruses and the blurring of traditional host boundaries.
- Diagnostic approaches for HPAI in poultry include clinical signs (acute mortality, depression, respiratory distress) and laboratory confirmation via rRT-PCR targeting matrix and hemagglutinin genes, with sequencing of the hemagglutinin cleavage site crucial for differentiating HPAI from LPAI.
- Pandemic preparedness necessitates enhanced biosecurity, strategic vaccination of poultry (with ongoing development of universal vaccines), rapid culling of infected flocks, and continuous monitoring for mammalian adaptation markers (e.g., PB2 mutations) to mitigate the risk of human transmission.
Influenza A viruses (IAVs) circulate broadly among wild aquatic birds, which serve as their natural reservoir [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. Avian influenza viruses (AIVs) of the H5 and H7 subtypes can evolve from low-pathogenicity (LPAI) to highly pathogenic (HPAI) forms through acquisition of a multibasic cleavage site in the hemagglutinin protein [<a href="#ref-3">3</a>]. Since the emergence of the A/goose/Guangdong/1/1996 lineage, HPAI H5 viruses have caused devastating losses in domestic poultry and have repeatedly spilled over into mammals, raising concerns about pandemic potential [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>]. The ongoing panzootic of H5N1 clade 2.3.4.4b has been characterized by unprecedented geographic spread, reassortment with local LPAI viruses, and frequent cross-species transmission events [<a href="#ref-6">6</a>, <a href="#ref-7">7</a>, <a href="#ref-8">8</a>]. This review synthesizes current knowledge on global surveillance networks, epidemiological patterns in poultry, diagnostic technologies, and control measures aimed at pandemic preparedness.
Poultry Pandemic: Epidemiological Context and Global Spread
The term "poultry pandemic" describes the sustained global circulation of HPAI H5 viruses that have caused mass mortality in domestic and wild birds across multiple continents [<a href="#ref-4">4</a>, <a href="#ref-5">5</a>]. The dominant strain shifted from H5N8 to H5N1 between 2019 and 2022, with clade 2.3.4.4b becoming the predominant genotype worldwide [<a href="#ref-8">8</a>, <a href="#ref-9">9</a>]. Phylogenetic analyses of H5N1 viruses detected in the United States from December 2021 to April 2022 revealed three independent introductions by wild birds, with subsequent reassortment generating at least 21 distinct genotypes [<a href="#ref-7">7</a>]. These reassortment events involved gene segments from Eurasian and North American wild bird AIVs, indicating that migratory birds are the primary vectors for intercontinental spread [<a href="#ref-10">10</a>, <a href="#ref-11">11</a>, <a href="#ref-12">12</a>].
In Europe, HPAI outbreaks have increased in frequency since 2014, with clade 2.3.4.4 viruses producing subtypes H5N1, H5N2, H5N3, H5N5, H5N6, and H5N8 [<a href="#ref-13">13</a>]. The 2016/2017 epidemic in Eurasia was the largest recorded at that time and was associated with multiple reassortants whose gene segments originated from both migratory wild birds and domestic anseriforms in Asia and Europe [<a href="#ref-12">12</a>]. Ecological divergence among avian hosts influences spillover dynamics; wild geese and swans act as source populations for HPAI H5, gulls facilitate rapid long-distance movement, and dabbling ducks contribute to geographic expansion [<a href="#ref-11">11</a>]. The Antarctic region, previously free of HPAIV, was breached in October 2023 when H5N1 clade 2.3.4.4b was detected in brown skuas at South Georgia, followed by infections in multiple avian and mammal species across the sub-Antarctic [<a href="#ref-14">14</a>]. These events underscore the role of wild bird migration and the inability of geographic barriers to contain the current panzootic.
Global Surveillance Networks: The Role of Avian Influenza CDC and WOAH
Global surveillance for avian influenza relies on coordinated efforts by national reference laboratories, the World Organisation for Animal Health (WOAH, formerly OIE), and agencies such as the Centers for Disease Control and Prevention (CDC) [<a href="#ref-15">15</a>, <a href="#ref-16">16</a>]. The integration of genomic surveillance, epidemiological data, and ecological monitoring is essential for early detection of emerging strains and for risk assessment [<a href="#ref-2">2</a>, <a href="#ref-15">15</a>]. The CDC maintains specialized laboratories that characterize AIV isolates from both human and animal sources, contributing to the WOAH/FAO global animal disease information system [<a href="#ref-16">16</a>]. The "avian influenza cdc" framework includes real-time reverse transcription PCR (rRT-PCR) protocols, sequencing pipelines, and antigenic cartography to monitor viral evolution and vaccine strain selection [<a href="#ref-15">15</a>, <a href="#ref-17">17</a>].
Whole genome sequencing of AIVs has become a cornerstone of surveillance, enabling phylodynamic analyses that track viral introductions, reassortment, and transmission pathways [<a href="#ref-7">7</a>, <a href="#ref-11">11</a>, <a href="#ref-12">12</a>]. Data sharing platforms such as GISAID (Global Initiative on Sharing All Influenza Data) facilitate rapid dissemination of sequences among public health and veterinary authorities [<a href="#ref-15">15</a>]. In Europe, risk-based surveillance integrates host ecology, bird banding data, and environmental sampling to improve early detection at the wild-domestic interface [<a href="#ref-2">2</a>, <a href="#ref-13">13</a>]. One Health approaches that link veterinary, environmental, and human health sectors are increasingly advocated to manage the threat of zoonotic AIVs [<a href="#ref-15">15</a>]. Continued investment in surveillance infrastructure, especially in regions with high poultry density and wild bird diversity, is critical for pandemic preparedness [<a href="#ref-16">16</a>].
Avian Influenza World Map: Geographic Distribution and Spillover Events
Mapping the "avian influenza world map" reveals the extraordinary geographic expansion of H5N1 clade 2.3.4.4b since 2020. The virus has been detected in over 48 mammal species across 26 countries, representing a substantial increase in host range compared to previous waves [<a href="#ref-6">6</a>]. Notable spillover events include infections in farmed minks in Spain, where onward mink-to-mink transmission was suspected and the PB2 mutation T271A was identified [<a href="#ref-18">18</a>]. Wild red foxes in the Netherlands exhibited neurotropism and harbored the PB2 E627K mammalian adaptation mutation, indicating that the virus can acquire adaptive changes within individual mammalian hosts [<a href="#ref-19">19</a>]. Gray seals in the Baltic Sea were found infected with H5N8 clade 2.3.4.4 group B, demonstrating spillover into marine mammals [<a href="#ref-20">20</a>]. Similarly, H5N1 caused mortality in New England seals, co-incident with infections in sympatric wild birds [<a href="#ref-21">21</a>].
The most alarming recent event is the spillover of H5N1 clade 2.3.4.4b into dairy cattle in the United States, detected in March 2024 [<a href="#ref-22">22</a>, <a href="#ref-23">23</a>]. Affected cows displayed decreased feed intake, altered fecal consistency, respiratory distress, and a sharp drop in milk production [<a href="#ref-23">23</a>]. The virus demonstrated a distinct tropism for mammary gland epithelium, with high viral loads detected in milk [<a href="#ref-23">23</a>, <a href="#ref-24">24</a>]. Cow-to-cow transmission was documented through transport of apparently healthy cows from affected farms to other states, indicating efficient mammal-to-mammal spread [<a href="#ref-22">22</a>, <a href="#ref-23">23</a>]. Additionally, domestic cats fed raw colostrum from infected cows developed fatal systemic influenza [<a href="#ref-22">22</a>]. Sialic acid receptor analysis of infected mammary tissue revealed abundant avian-type α2,3-galactose receptors, accounting for the tropism [<a href="#ref-24">24</a>]. These findings emphasize that the current panzootic is blurring the traditional boundaries between avian and mammalian hosts, heightening pandemic risk.
Clinical Signs in Poultry and Diagnostic Approaches
Clinical signs of HPAI in poultry are variable but often include acute mortality, depression, cyanosis of combs and wattles, edema of the head and neck, respiratory distress, diarrhea, and drop in egg production [<a href="#ref-2">2</a>, <a href="#ref-3">3</a>]. In low-pathogenicity infections, clinical signs may be mild or absent, complicating early detection [<a href="#ref-1">1</a>]. Differential diagnoses include Newcastle disease, infectious laryngotracheitis, and bacterial infections such as fowl cholera or mycoplasmosis [<a href="#ref-2">2</a>]. Ante-mortem diagnosis relies on sampling of oropharyngeal and cloacal swabs, followed by virus detection.
Diagnostic methods for H5N1 AIV have advanced considerably. Molecular techniques such as rRT-PCR targeting the matrix gene and subtype-specific hemagglutinin genes are the gold standard for rapid detection and subtyping [<a href="#ref-17">17</a>]. Conventional and real-time PCR assays can be performed on a variety of specimens including swabs, tissues, and milk [<a href="#ref-17">17</a>, <a href="#ref-23">23</a>]. Sequencing of the hemagglutinin cleavage site is required to differentiate HPAI from LPAI strains [<a href="#ref-3">3</a>]. Serological methods (hemagglutination inhibition, ELISA) are used for surveillance but require paired sera and confirmation by neutralization assays [<a href="#ref-17">17</a>].
Biosensor-based platforms, including electrochemical and optical sensors, offer potential for field-deployable detection [<a href="#ref-17">17</a>]. An innovative approach using chicken sound analysis and convolutional neural networks achieved recognition accuracy above 95% for H9N2-infected chickens, providing a non-invasive screening tool [<a href="#ref-25">25</a>]. Genetic detection methods (e.g., loop-mediated isothermal amplification) are also being developed for rapid point-of-care testing [<a href="#ref-17">17</a>]. For comprehensive genomic surveillance, high-throughput sequencing enables full-genome characterization, detection of reassortment events, and identification of mammalian adaptation markers [<a href="#ref-7">7</a>, <a href="#ref-26">26</a>].
Pandemic Preparedness: Vaccine Development and Control Measures
Pandemic preparedness for avian influenza relies on a combination of vaccination strategies, biosecurity, and culling. Vaccination of poultry can reduce viral shedding and prevent clinical disease, but vaccine strain selection must be regularly updated to match circulating field strains [<a href="#ref-27">27</a>]. H5-specific vaccines and universal influenza vaccines that target conserved regions (e.g., the hemagglutinin stalk, matrix protein 2 ectodomain) are under development to provide broader protection against multiple subtypes [<a href="#ref-9">9</a>, <a href="#ref-28">28</a>]. In animal models, these vaccines have shown promise, but clinical trials in humans remain limited [<a href="#ref-28">28</a>].
Control measures in poultry include enhanced biosecurity (e.g., preventing contact with wild birds, disinfection protocols, controlled movement of birds) and rapid culling of infected flocks [<a href="#ref-2">2</a>, <a href="#ref-27">27</a>]. In China, a combination of mass vaccination and improved biosecurity has been used to control H5, H7, and H9 subtypes, though vaccine efficacy can be compromised by antigenic drift [<a href="#ref-27">27</a>]. Experience in Europe and North America demonstrates that rapid detection, stamping out, and movement restrictions can contain outbreaks, but the scale of the current panzootic challenges these traditional approaches [<a href="#ref-13">13</a>, <a href="#ref-16">16</a>].
Preparedness also requires monitoring of molecular markers associated with mammalian adaptation. Key mutations such as PB2 E627K, D701N, and T271A enhance polymerase activity in mammalian cells and have been detected in mammalian isolates [<a href="#ref-9">9</a>, <a href="#ref-18">18</a>, <a href="#ref-19">19</a>, <a href="#ref-26">26</a>]. Receptor-binding specificity remains a critical barrier; avian influenza viruses preferentially bind α2,3-linked sialic acids, whereas human influenza viruses bind α2,6-linked receptors [<a href="#ref-24">24</a>, <a href="#ref-29">29</a>]. The swine host, which expresses both receptor types, may act as a mixing vessel for reassortment and adaptation, mediated by the host factor ANP32A that supports avian polymerase activity [<a href="#ref-30">30</a>].
Conclusion
The global surveillance of avian influenza virus has entered a new era marked by the relentless spread of clade 2.3.4.4b H5N1 into diverse avian and mammalian hosts, including dairy cattle. The current "poultry pandemic" demonstrates that HPAI viruses are no longer confined to birds and that interspecies transmission events are increasing in frequency and geographic range. Surveillance networks coordinated by the "avian influenza cdc" and WOAH provide the backbone for early detection, but continued investment in genomic sequencing, ecological monitoring, and data sharing is essential. An updated "avian influenza world map" must now include not only poultry and wild birds but also a growing list of mammalian species, each representing potential bridge hosts for adaptation to humans. Controlling this panzootic requires integrated One Health strategies, including rigorous biosecurity, strategic vaccination, and rapid diagnostics. Pandemic preparedness depends on sustained vigilance and the capacity to respond swiftly to the emergence of viruses with enhanced mammalian transmissibility.
Related Clinical & Scientific Guides
- Duck Diseases: A Comprehensive Overview for Veterinary Practitioners
- Salmonella Dublin in Cattle: Emerging Pathogen, Diagnostic Challenges, and Public Health Impact
- Mycoplasma Infections in Poultry: Vaccination Strategies and Control Programs